RED BANK, NEW JERSEY / ACCESS Newswire / August 13, 2025 / Tharimmune, Inc. (Nasdaq:THAR) (“Tharimmune” or the “Company”), a clinical-stage biotechnology company dedicated to developing innovative ...

An unexpected update to a Nintendo patent for a 3-screen DS-style device is fueling speculation for potential Switch 2 upgrades.

After taking a $50 million hit in a patent lawsuit targeting its leukemia med Blincyto last year, Amgen has convinced a ...

Morning. Today, we see march-in rights return to the headlines, ponder how Eli Lilly’s plan to hike list prices in Europe may ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...